420 Lexington Avenue
Suite 350
New York, New York 10170
Telephone: 1.212.584.4180

Targeted Cancer Immunotherapy Program

A Focus on Investigating Treatments for Cancer

NeoStem is developing an immunotherapy which uses a patient’s own tumor cells to maximize the ability of their immune system to identify and eliminate the cancer initiating (stem) cells that are capable of reconstituting or developing new tumors.

Our proposed therapeutics combine the patient’s own purified and irradiated cancer cells with specialized immune cells, educating the immune cells to destroy the cancer initiating (stem) cells from which tumors arise.

NeoStem - Cell Therapy Development - Clinical